全文获取类型
收费全文 | 45716篇 |
免费 | 4486篇 |
国内免费 | 53篇 |
专业分类
耳鼻咽喉 | 639篇 |
儿科学 | 1259篇 |
妇产科学 | 1259篇 |
基础医学 | 7003篇 |
口腔科学 | 1052篇 |
临床医学 | 6115篇 |
内科学 | 8423篇 |
皮肤病学 | 596篇 |
神经病学 | 3669篇 |
特种医学 | 1477篇 |
外国民族医学 | 1篇 |
外科学 | 6034篇 |
综合类 | 916篇 |
一般理论 | 29篇 |
预防医学 | 4692篇 |
眼科学 | 677篇 |
药学 | 3648篇 |
1篇 | |
中国医学 | 61篇 |
肿瘤学 | 2704篇 |
出版年
2021年 | 640篇 |
2020年 | 451篇 |
2019年 | 743篇 |
2018年 | 810篇 |
2017年 | 581篇 |
2016年 | 724篇 |
2015年 | 756篇 |
2014年 | 1037篇 |
2013年 | 1579篇 |
2012年 | 2102篇 |
2011年 | 2161篇 |
2010年 | 1216篇 |
2009年 | 1087篇 |
2008年 | 1884篇 |
2007年 | 1953篇 |
2006年 | 1914篇 |
2005年 | 1872篇 |
2004年 | 1793篇 |
2003年 | 1743篇 |
2002年 | 1770篇 |
2001年 | 1559篇 |
2000年 | 1591篇 |
1999年 | 1378篇 |
1998年 | 612篇 |
1997年 | 510篇 |
1996年 | 433篇 |
1995年 | 470篇 |
1994年 | 436篇 |
1993年 | 407篇 |
1992年 | 1118篇 |
1991年 | 1053篇 |
1990年 | 1030篇 |
1989年 | 950篇 |
1988年 | 873篇 |
1987年 | 901篇 |
1986年 | 868篇 |
1985年 | 885篇 |
1984年 | 705篇 |
1983年 | 602篇 |
1982年 | 427篇 |
1981年 | 349篇 |
1980年 | 361篇 |
1979年 | 578篇 |
1978年 | 440篇 |
1977年 | 361篇 |
1976年 | 369篇 |
1974年 | 379篇 |
1973年 | 333篇 |
1972年 | 338篇 |
1971年 | 304篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
92.
93.
94.
Nicole Andrews Laura L. Jones Naiem Moiemen Melanie Calvert Philip Kinghorn Ian Litchfield Jonathan Bishop Jonathan J. Deeks Jonathan Mathers 《Burns : journal of the International Society for Burn Injuries》2018,44(3):626-635
Introduction
Parents have a crucial role to play in burn scar management for their children at a time that is extremely stressful for them and their child. Scar management treatments such as pressure garment therapy (PGT) require high levels of adherence. There has been a lack of research into the factors that may influence adherence in paediatric burn scar management. This qualitative research study has investigated parents’ experiences of scar management and their attempts to adhere to treatment at home. The aim of this paper is to outline parents’ views on the factors that influence adherence.Methods
25 parents of paediatric and adolescent burn patients took part in semi-structured interviews. Participants were recruited from three UK burns services. Interviews were conducted in a participant-focussed manner and topics for discussion included parents’ accounts of treatment and their experience of PGT. A thematic analysis was undertaken.Results
Four overarching themes describe parents’ views and experiences of scar management and adherence. These are the transition from hospital to home; the practical realities of treatment; the emotional labour involved in treatment and; negotiating treatment and regime. The transition from hospital to home is a significant event for parents. They may be apprehensive about this at the same time as they desire that they and their child return to some sense of normality following the burn injury. Parents are required to adopt the role of therapeutic caregiver upon transition from hospital to home. Adherence to scar management is influenced by the practical realities of maintaining treatment (routine, division of care labour, hospital appointments) and the emotional labour involved in doing so. The latter demands that parents manage their own and their children’s emotions. Approaches to adherence were often described as flexible in response to these influences.Conclusions
Some parents negotiate the realities and demands of scar management successfully, whereas others do not. The emotional labour experienced by parents and their ability to cope with this is often a strong influence on their views regarding adherence to scar management. Further research is needed to explore how burns services and staff manage this at present, and whether simple interventions can help with the key practical and emotional influences on treatment adherence. 相似文献95.
96.
97.
98.
99.
Amelia Pietropaolo Patrick Jones Mike Moors Brian Birch Bhaskar K. Somani 《Current urology reports》2018,19(10):78
Purpose of Review
Intravesical antibiotics (IVA) has been used for prophylaxis and treatment of recurrent urinary tract infections (rUTIs). However, there is a lack of comprehensive evidence and consensus on its use. We conducted a systematic review to collect all available data about the effectiveness of IVA in prevention and treatment of rUTIs and to give an overview on the outcomes to date.Methods
A systematic review was carried out for all English language articles from inception to August 2017, according to the Cochrane and PRISMA standards using MEDLINE, Scopus, Biomed Central, EMBASE, CINAHL, and Web of Science with references cross-checked and individual urology journals hand-searched.Results
After an initial identification of 658 studies, we screened 37 abstracts and 18 full-text papers of which 11 were included in our final review. This included 285 patients with a mean age of 52 years and a female:male ratio of 129:117. The IVA used was gentamicin, neomycin/polymyxin, neomycin or colistin and IVA was used for rUTIs as prophylaxis in 5 studies (n?=?168) and treatment in 6 studies (n?=?117). Overall, a good reduction in symptomatic UTI was seen in 78%, with a short-term success rate and discontinuation rates of 71% (120/168) and 8% (14/168) in the prophylaxis group and 88% (103/117) and 5% (6/117) in the treatment groups respectively. There was a change in the sensitivity of organisms in 30% (50/168) and 23% (27/117) in the treatment and prophylaxis groups respectively. Twenty patients discontinued their IVA instillations which were higher for the non-gentamicin group (11%) compared to the gentamicin group (5%). The side effects were minor and included allergy, suprapubic discomfort, autonomic dysreflexia, urinary tract infections and diarrhoea.Summary
Intravesical antimicrobial instillation seems to be a relatively safe and effective method for the prophylaxis and treatment of recurrent UTIs, especially in the short term. It gives clinicians an alternative treatment modality in high-risk patients predisposed to UTIs where all other forms of systemic treatments have failed.100.
Kevin D. Hyde Abdullah M. S. Al-Hatmi Birgitte Andersen Teun Boekhout Walter Buzina Thomas L. DawsonJr. Dan C. Eastwood E. B. Gareth Jones Sybren de Hoog Yingqian Kang Joyce E. Longcore Eric H. C. McKenzie Jacques F. Meis Laetitia Pinson-Gadais Achala R. Rathnayaka Florence Richard-Forget Marc Stadler Bart Theelen Benjarong Thongbai Clement K. M. Tsui 《Fungal Diversity》2018,93(1):161-194
An account is provided of the world’s ten most feared fungi. Within areas of interest, we have organized the entries in the order of concern. We put four human pathogens first as this is of concern to most people. This is followed by fungi producing mycotoxins that are highly harmful for humans; Aspergillus flavus, the main producer of aflatoxins, was used as an example. Problems due to indoor air fungi may also directly affect our health and we use Stachybotrys chartarum as an example. Not everyone collects and eats edible mushrooms. However, fatalities caused by mushroom intoxications often make news headlines and therefore we include one of the most poisonous of all mushrooms, Amanita phalloides, as an example. We then move on to the fungi that damage our dwellings causing serious anxiety by rotting our timber structures and flooring. Serpula lacrymans, which causes dry rot is an excellent example. The next example serves to represent all plant and forest pathogens. Here we chose Austropuccinia psidii as it is causing devastating effects in Australia and will probably do likewise in New Zealand. Finally, we chose an important amphibian pathogen which is causing serious declines in the numbers of frogs and other amphibians worldwide. Although we target the top ten most feared fungi, numerous others are causing serious concern to human health, plant production, forestry, other animals and our factories and dwellings. By highlighting ten feared fungi as an example, we aim to promote public awareness of the cost and importance of fungi. 相似文献